| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/17/2013 | CN103204923A Preparation of carperitide by solid-phase convergence process |
| 07/17/2013 | CN103204922A Method for preparing nesiritide |
| 07/17/2013 | CN103204921A Secretory protein with chemotactic activity, and coding sequence and application thereof |
| 07/17/2013 | CN103204920A Novel epidermal growth factors and applications for same |
| 07/17/2013 | CN103204919A Specific marker Aire (Autoimmune Regulator) of embryonic stem cells and application thereof |
| 07/17/2013 | CN103204918A Specific marker Glut3 (Glucose Transporter 3) of embryonic stem cells and application thereof |
| 07/17/2013 | CN103204917A Sugar cane sucrose transport protein ShSUT3 and application of coding gene thereof |
| 07/17/2013 | CN103204916A Sugarcane cane sugar transport protein ShSUT2 type genes and application thereof |
| 07/17/2013 | CN103204915A Salt resistance related protein IbEST of sweet potato and coding gene and application thereof |
| 07/17/2013 | CN103204914A MIPI gene and application thereof |
| 07/17/2013 | CN103204913A Atriplex hortensis transcriptional active protein AhPHD1, its coding gene and application |
| 07/17/2013 | CN103204912A Insecticidal gene cry2Ah-like with high toxicity on lepidoptera pest and application thereof |
| 07/17/2013 | CN103204911A Targeting Vector-phospholipid Conjugates |
| 07/17/2013 | CN102603882B Antifungal peptide as well as preparation method and application thereof |
| 07/17/2013 | CN102586281B Gene with salt resistant function, encoding protein thereof and application of encoding protein |
| 07/17/2013 | CN102558340B Glucagon-like peptide (GLP)-1 derivative |
| 07/17/2013 | CN102558339B GLP-1(Glucagon-like Peptide 1) derivative |
| 07/17/2013 | CN102533798B Recombinant denovirus for expressing foot-and-mouth disease virus type A empty capsid, and application thereof |
| 07/17/2013 | CN102532300B Interferon alpha mutant and polyethylene glycol derivative thereof |
| 07/17/2013 | CN102532299B Interferon alpha mutant and polyethylene glycol derivative thereof |
| 07/17/2013 | CN102391370B Antimicrobial peptides, preparation method and application thereof |
| 07/17/2013 | CN102367276B Plant resistance related protein ZIP11, its encoding gene and application thereof |
| 07/17/2013 | CN102367272B Plant resistance related protein ANAC001, its encoding gene and application thereof |
| 07/17/2013 | CN102295690B Disease tolerance related protein, and coding gene and application thereof |
| 07/17/2013 | CN102250922B CDNA sequence of FT gene in phalaenopsis and amino acid sequence coded by same |
| 07/17/2013 | CN102174485B Aspergillus immunodominance antigen and application thereof |
| 07/17/2013 | CN101939436B Maize stress-responsive NAC transcription factors and promoter and methods of use |
| 07/17/2013 | CN101921330B Recombinant human interferon alpha 1b mutant and preparation method thereof |
| 07/17/2013 | CN101918443B Antigen associated with rheumatoid arthritis |
| 07/17/2013 | CN101914150B Polypeptide and use thereof in medicament preparation |
| 07/17/2013 | CN101848928B Staphylokinase variant |
| 07/17/2013 | CN101824455B Soy protein oligopeptide, and preparation method and use thereof |
| 07/17/2013 | CN101724555B Whey protein antihypertensive peptide prepared by utilizing continuous enzyme membrane reactor and special device thereof |
| 07/17/2013 | CN101679495B Short bio-active peptides for cellular and immunological modulation |
| 07/17/2013 | CN101622272B Modified flagellin improved toll-like receptor 5 stimulating activity |
| 07/17/2013 | CN101605810B Chimeric human sweet-umami and umami-sweet taste receptors |
| 07/17/2013 | CN101578102B Glucagon analogs exhibiting enhanced solubility in physiological pH buffers |
| 07/17/2013 | CN101522708B Peptides having activities of epidermal growth factor and its uses |
| 07/17/2013 | CN101495507B Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 07/17/2013 | CN101472943B SPARC-derived cancer rejection antigen peptide and pharmaceutical comprising the same |
| 07/17/2013 | CN101397564B Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 07/17/2013 | CN101389648B Oxyntomodulin derivatives |
| 07/17/2013 | CN101360999B Intraocular pressure-regulated early genes and uses thereof |
| 07/17/2013 | CN101107361B Recombinant expression of proteins in a disulfide-bridged, two-chain form |
| 07/16/2013 | US8487165 Inbred maize variety PH18WD |
| 07/16/2013 | US8487164 Maize variety inbred PHP5E |
| 07/16/2013 | US8487163 Maize variety inbred PH134R |
| 07/16/2013 | US8487075 Alpha-conotoxin peptides |
| 07/16/2013 | US8487074 Modulation of lipid rafts |
| 07/16/2013 | US8486893 Treatment of conditions involving demyelination |
| 07/16/2013 | US8486891 Nasal calcitonin formulations containing chlorobutanol |
| 07/16/2013 | US8486887 Enhancement of Bacillus thuringiensis Cry protein toxicities to coleopterans, and novel insect cadherin fragments |
| 07/16/2013 | US8486886 Botulinum toxin treatments |
| 07/16/2013 | US8486716 Method for detection of basic peptide and reagent for detection of basic peptide |
| 07/16/2013 | US8486688 Use of psychrophilic anaerobic digestion in sequencing batch reactor for degradation of prions |
| 07/16/2013 | US8486685 Cellular permissivity factor for viruses and uses thereof |
| 07/16/2013 | US8486681 Alpha-amylase variant with altered properties |
| 07/16/2013 | US8486666 Removal of the guanine cap on the 5′ terminus of RNA |
| 07/16/2013 | US8486647 Neuropeptide release assay for sodium channels |
| 07/16/2013 | US8486643 Methods relating to mammalian raptor polypeptide |
| 07/16/2013 | US8486467 Dermal filler and method of using same |
| 07/16/2013 | US8486438 Methods for progenitor cell recruitment and isolation |
| 07/16/2013 | US8486419 Flavivirus mutant has a deletion in the capsid protein of at least more than 4 successive amino acids, wherein the carboxy terminal hydrophobic region is not affected by the deletion |
| 07/16/2013 | US8486416 Use of SDF-1 to improve ischemic myocardial function |
| 07/16/2013 | US8486414 Immunogenic compositions comprising Mycobacterium tuberculosis polypeptides and fusions thereof |
| 07/16/2013 | US8486384 Lipidized interferon and methods of treating viral hepatitis |
| 07/16/2013 | US8486383 Method of treating pulmonary disease with interferons |
| 07/16/2013 | CA2599463C Porcine instrinsic factor and uses thereof in diagnostic tests for vitamin b12 |
| 07/16/2013 | CA2591786C Prevention of thrombus formation and/or stabilization |
| 07/16/2013 | CA2533522C Amino acid-substituted coagulation factor v |
| 07/16/2013 | CA2526695C Selection of allosteric regulators with class iii g protein-coupled receptors depleted of the extracellular domain |
| 07/16/2013 | CA2516834C Polypeptides and methods for making the same |
| 07/16/2013 | CA2512138C Kim-1 antagonists and use to modulate immune system |
| 07/16/2013 | CA2490542C Fas peptide mimetics and uses thereof |
| 07/16/2013 | CA2476890C Subtilisin carlsberg proteins with reduced immunogenicity |
| 07/16/2013 | CA2448348C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/16/2013 | CA2425486C Flea peritrophin nucleic acid molecules, proteins and uses thereof |
| 07/16/2013 | CA2395406C Method for treating inflammation |
| 07/16/2013 | CA2358684C Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/16/2013 | CA2350334C New family of mammalian potassium channels, their cloning and their use, especially for the screening of drugs |
| 07/16/2013 | CA2289742C Method for generating activated t-cells and antigen-pulsed antigen-presenting cells |
| 07/16/2013 | CA2253441C Glycoprotein hormone superagonists |
| 07/11/2013 | WO2013103981A1 Compositions and methods of use of fndc5 polypeptides |
| 07/11/2013 | WO2013103896A1 Treating cardiovascular or renal diseases |
| 07/11/2013 | WO2013103816A1 Partial mhc constructs and methods of use |
| 07/11/2013 | WO2013103658A1 Native and agonist ctl epitopes of the muc1 tumor antigen |
| 07/11/2013 | WO2013103628A1 Peptides and methods for detecting mpo-anca |
| 07/11/2013 | WO2013103370A1 Methods and compositions for modulating expression or activity of a rkd polypeptide in a plant |
| 07/11/2013 | WO2013103369A1 Compositions and methods for the expression of a sequence in a reproductive tissue of a plant |
| 07/11/2013 | WO2013102937A2 Method for effective management of helicoverpa armigera |
| 07/11/2013 | WO2013102692A1 Rgd biomimetic peptide with affinity domain for type-i collagen and the uses thereof as osteogenic factor |
| 07/11/2013 | WO2013102684A1 Affinity tag system |
| 07/11/2013 | WO2013102659A2 Binding agents to intracellular target molecules |
| 07/11/2013 | WO2013102458A1 Method for producing an examination reagent and kit for analysing a t-cell frequency |
| 07/11/2013 | WO2013102265A1 Compositions and methods for treating multiple sclerosis |
| 07/11/2013 | WO2013102264A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
| 07/11/2013 | WO2013074871A3 Humanin analogs |
| 07/11/2013 | WO2013050024A3 Transgenic plant of the species beta vulgaris having enhanced resistance to cercospora |
| 07/11/2013 | WO2013023070A3 Plants with altered glucuronoxylan methyl transferase activity and methods of use |
| 07/11/2013 | WO2013020090A3 STREPTOCOCCAL GLcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM |